Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rowlinson-Busza

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Methods in Molecular Medicine|February 22, 2011
Animal models for tumor localizationG Rowlinson-Busza
Methods in Molecular Medicine|February 22, 2011
Determination of the immunoreactivity of radiolabeled monoclonal antibodiesG Rowlinson-Busza
Current Opinion in Oncology|December 1, 1992
Targeted delivery of biologic and other antineoplastic agentsG Rowlinson-Busza, A A Epenetos
British Journal of Cancer|April 1, 1995
Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft modelG Rowlinson-Busza, A Maraveyas, A A Epenetos
International Journal of Radiation Oncology, Biology, Physics|March 30, 1994
90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTAG Rowlinson-Busza, D Snook, A A Epenetos
International Journal of Cancer|November 15, 1995
Specific targeting of a mutant, activated FGF receptor found in glioblastoma using a monoclonal antibodyD Hills, G Rowlinson-Busza, W J Gullick
International Journal of Cancer|December 2, 1998
In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibodyK N Syrigos, G Rowlinson-Busza, A A Epenetos
Journal of Comparative Pathology|March 24, 1999
Phenotypic characterization of histiocytes infiltrating a leiomyofibrosarcomaA Whyte, G Rowlinson-Busza, A Dorling, et al.
Cancer Research|June 15, 1991
Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injectionG Rowlinson-Busza, A Bamias, T Krausz, et al.
International Journal of Cancer|November 10, 1998
Improving tumour targeting and decreasing normal tissue uptake by optimizing the stoichiometry of a two-step biotinylated-antibody/streptavidin-based targeting strategy: studies in a nude mouse xenograft modelA Maraveyas, G Rowlinson-Busza, S Murray, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Methods in Molecular Medicine|February 22, 2011
Animal models for tumor localizationG Rowlinson-Busza
Methods in Molecular Medicine|February 22, 2011
Determination of the immunoreactivity of radiolabeled monoclonal antibodiesG Rowlinson-Busza
Current Opinion in Oncology|December 1, 1992
Targeted delivery of biologic and other antineoplastic agentsG Rowlinson-Busza, A A Epenetos
British Journal of Cancer|April 1, 1995
Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft modelG Rowlinson-Busza, A Maraveyas, A A Epenetos
International Journal of Radiation Oncology, Biology, Physics|March 30, 1994
90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTAG Rowlinson-Busza, D Snook, A A Epenetos
International Journal of Cancer|November 15, 1995
Specific targeting of a mutant, activated FGF receptor found in glioblastoma using a monoclonal antibodyD Hills, G Rowlinson-Busza, W J Gullick
International Journal of Cancer|December 2, 1998
In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibodyK N Syrigos, G Rowlinson-Busza, A A Epenetos
Journal of Comparative Pathology|March 24, 1999
Phenotypic characterization of histiocytes infiltrating a leiomyofibrosarcomaA Whyte, G Rowlinson-Busza, A Dorling, et al.
Cancer Research|June 15, 1991
Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injectionG Rowlinson-Busza, A Bamias, T Krausz, et al.
International Journal of Cancer|November 10, 1998
Improving tumour targeting and decreasing normal tissue uptake by optimizing the stoichiometry of a two-step biotinylated-antibody/streptavidin-based targeting strategy: studies in a nude mouse xenograft modelA Maraveyas, G Rowlinson-Busza, S Murray, et al.
Pageof 3